Found 9 dm-renal-electrolyte-and-hypertension trials
A listing of dm-renal-electrolyte-and-hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
To demonstrate the effectiveness and the safety of the TIVUS system in: a) subjects with hypertension (HTN) receiving up to 2 anti-hypertensive drugs of different classes in whom tb) subjects with controlled hypertension receiving up to 2 anti-hypertensive drugs of different classes
This study examines the safety, tolerability, and effectiveness of AZD2373 in APOL1-Mediated Kidney Disease (AMKD). Some people have a variant in the APOL1 gene that is associated with protection against African sleeping sickness but increases the risk of kidney disease in some people. There is currently no approved treatment for …
MZE829-201 is a Phase 2, open-label study of MZE829 in adults aged 18 to 65 years with proteinuric chronic kidney disease (CKD) and the APOL1 high risk genotype, or APOL1 Kidney Disease (AKD). It aims to evaluate the safety and tolerability of MZE829 in adults with proteinuric AKD, to evaluate …
This research study is being done to learn about the effects of the study drug, Atacicept, on reducing damage to the kidneys and to see how safe the study drug is for people with IgA nephropathy (IgAN), IgA vasculitis with nephritis (IgAVN), primary membranous nephropathy (pMN), minimal change disease (MCD), …
To evaluate the efficacy of felzartamab compared with placebo in kidney transplant recipients diagnosed with C4d-positive or C4d-negative DSA-negative MVI.
The purpose of this study is to investigate ADPKD, focusing on the PKD1/2 gene variants. The study looks at how common these gene variants are and the characteristics of people who have them.This study evaluates the different traits and demographics of individuals with these gene variants. It explores the clinical …
To assess the feasibility and acceptability of a home-based prehabilitation intervention among kidney transplant candidates; to acquire preliminary data regarding the effects of a home-based prehabilitation intervention on improving physical activity and function and frailty components among kidney transplant candidates; and to evaluate the early efficacy of a home-based prehabilitation …
This is a Phase 3b, multicenter, open-label extension (OLE) study to evaluate the efficacy and safety of Nefecon treatment in patients with IgAN who have completed the Phase 3 Study Nef 301 and continue to be treated with a stable dose of RAS inhibitor therapy (ACEIs and/or ARBs). Patients who …
Please choose between Voice or SMS based delivery of verification code
or